US Patent 7393958 Triamide-substituted heterobicyclic compounds

Patent 7393958 was granted and assigned to Pfizer on July, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Pfizer

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7393958

Patent Inventor Names

Michel A. Couturier0

Marcus D. Ewing0

Ralph P. Robinson0

Peter Bertinato0

Derek L. Tickner0

Ernest S. Hamanaka0

Date of Patent

July 1, 2008

Patent Application Number

11554351

Date Filed

October 30, 2006

Patent Primary Examiner

‌

D. Margaret Seaman

Patent abstract

This invention relates to MTP/Apo-B secretion inhibitors of Formula (I)

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7393958 Triamide-substituted heterobicyclic compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API